‘Do Not Rely On The Brexit Transition Period!’ EC Warns Hesitant Pharma Firms

 
• By Ian Schofield

Pharmaceutical companies have been urged by the European Commission to press ahead with their contingency planning for Brexit, amid signs some firms are taking a “wait-and-see” approach.

Brexit chess
The European Commission says pharma firms need to act now and not rely on a Brexit transition period.

More from Europe

More from Geography